Omicron cases in Colorado are surging with staggering infection rates and eye-popping positivity results — well over 25% for those seeking COVID-19 tests.
Todd Neff has written hundreds of stories for University of Colorado Hospital and UCHealth. He covered science and the environment for the Daily Camera in Boulder, Colorado, and has taught narrative nonfiction at the University of Colorado, where he was a Ted Scripps Fellowship recipient in Environmental Journalism. He is author of “A Beard Cut Short,” a biography of a remarkable professor; “The Laser That’s Changing the World,” a history of lidar; and “From Jars to the Stars,” a history of Ball Aerospace.
Two years may feel like an eternity to a world-weary of the coronavirus pandemic. In terms of scientific development, it’s been the blink of an eye, and we’ve learned a lot during that blink.
While vaccination provides excellent protection from COVID-19, if you end up with the coronavirus, monoclonal antibodies can shorten the duration of the disease while cutting the chance of ending up in the hospital by a solid 70%.
Colorado has the fifth-highest 7-day, per-capita coronavirus case count in the United States, and state forecasters say it’s going to get worse before it gets better. Yet the state’s vaccination rate ranks among the top one-third in the country, with about 72% of the state’s eligible population now fully vaccinated.
Perhaps you’ve had COVID-19 already. Perhaps you’ve had one of the two vaccine doses but heard that you may feel under the weather the day after that second shot and are putting it off. Perhaps you figure you’re young and healthy and aren’t going to get all that sick even if you do catch the coronavirus. Or perhaps something else is keeping you from being vaccinated.
Although less than half the U.S. population has been fully immunized against COVID-19, medical experts and vaccine specialists are studying and preparing for the need for COVID-19 booster shots. Here’s a rundown of some of the big questions and answers – many of them tentative, as it’s still early days – having to do with coronavirus booster shots.